Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Thyroid tests may not be needed for all vitiligo and alopecia areata patients unless thyroid disease symptoms appear.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Topical minoxidil and anthralin work for patchy alopecia areata but not for alopecia totalis/universalis.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Antiandrogens like spironolactone can help treat female-pattern hair loss.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

The man's hair loss and skin papules were diagnosed as atrichia with papular lesions, not alopecia areata universalis.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.